Profile to comeSkyline Diagnostics develops and commercializes diagnostic microarrays (Profilers) for patients with cancer. The companies pipeline consists of 4 products based on gene expression that offer a high additive clinical value. Skyline Diagnostics’ Profilers provide the clinician in-depth insight in the prognosis of individual patients and facilitate the treatment decision making process. The first product, the AMLProfiler, was launched in January 2010. Remote analysis using a secure central server in combination with the Affimetrix GeneChip® System makes the commercial process scalable. The company has built strong collaborations with leading scientists and has strategic alliances with industrial partners for distribution and manufacturing.

Web: www.skyline-diagnostics.com